drugset / Trial / NCT00837655

Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)

NCT00837655

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to perform a randomized, controlled clinical trial to investigate if the phosphate binder sevelamer can improve insulin resistance and glucose handling in patients receiving maintenance hemodialysis.

Timeline

Start
2009-01
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium carbonate Other / unclassified 250 mg
Subject Sevelamer Other / unclassified 4800 mg